A case of atopic dermatitis with self-healing acute diffuse and total alopecia during nemolizumab treatment

The Journal of DermatologyEarly View LETTER TO THE EDITOR A case of atopic dermatitis with self-healing acute diffuse and total alopecia during nemolizumab treatment Masataka Suehiro, Masataka Suehiro orcid.org/0009-0001-9564-0427 Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanSearch for more papers by this authorAkio Tanaka, Corresponding Author Akio Tanaka [email protected] orcid.org/0000-0002-5354-7064 Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Correspondence Akio Tanaka, Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Email: [email protected]Search for more papers by this author Masataka Suehiro, Masataka Suehiro orcid.org/0009-0001-9564-0427 Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, JapanSearch for more papers by this authorAkio Tanaka, Corresponding Author Akio Tanaka [email protected] orcid.org/0000-0002-5354-7064 Department of Dermatology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan Correspondence Akio Tanaka, Department of Dermatology, Institute of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami-ku, Hiroshima 734-8551, Japan. Email: [email protected]Search for more papers by this author First published: 06 November 2023 https://doi.org/10.1111/1346-8138.17023Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Kabashima K, Matsumura T, Komazaki H, Kawashima M. Trial of nemolizumab and topical agents for atopic dermatitis with pruritus. N Engl J Med. 2020; 383: 141–150. 2Bain KA, McDonald E, Moffat F, Tutino M, Castelino M, Barton A, et al. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity. Br J Dermatol. 2020; 182: 130–137. 3Lu Z, Zeng N, Cheng Y, Chen Y, Li Y, Lu Q, et al. Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2021; 17: 1–9. 4Fukuyama M, Kinoshita-Ise M, Mizukawa Y, Ohyama M. Two-sided influence of dupilumab on alopecia areata co-existing with severe atopic dermatitis: a case series and literature review. J Cutan Immunol Allergy. 2023; 6: 13–17. 5Fukuyama M, Kinoshita-Ise M, Sato Y, Ohyama M. Elucidation of demographic, clinical and trichoscopic features for early diagnosis of self-healing acute diffuse and total alopecia. J Dermatol. 2020; 47: 583–591. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation